Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schweizer

Showing results (31-40 of 267) with videos related to

Pageof 27
Sort By:
Connecticut Medicine|November 1, 1970
Misplaced central venous pressure cathetersR T Schweizer, J H Foster
Therapeutic Advances in Urology|August 2, 2012
Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is bornMichael T Schweizer, Emmanuel S Antonarakis
Archives of Surgery (Chicago, Ill. : 1960)|May 1, 1988
Use of oxygen radical scavengers on autografted pig kidneys after warm ischemia and 48-hour perfusion preservationP J Bosco, R T Schweizer
Medical Hypotheses|August 1, 1986
The LAV/HTLV-III virus may evade elimination by the immune system by inducing low zone tolerance to itselfR J Sharpe, R T Schweizer
Expert Opinion on Therapeutic Targets|March 2, 2016
Targeting constitutively active androgen receptor splice variants in castration resistant prostate cancerM T Schweizer, S R Plymate
Clinical Advances in Hematology & Oncology : H&O|October 18, 2017
Prognostic and therapeutic implications of DNA repair gene mutations in advanced prostate cancerMichael T Schweizer, Emmanuel S Antonarakis
Transplantation|October 1, 1982
Effect of different magnesium levels in kidney preservation perfusateR T Schweizer, B A Sutphin
Cancer Metastasis Reviews|January 31, 2014
Immunotherapy for prostate cancer: recent developments and future challengesMichael T Schweizer, Charles G Drake
Journal of Hematology & Oncology|November 15, 2015
Persistent androgen receptor addiction in castration-resistant prostate cancerMichael T Schweizer, Evan Y Yu
Asian Journal of Andrology|January 18, 2014
Chemotherapy and its evolving role in the management of advanced prostate cancerMichael T Schweizer, Emmanuel S Antonarakis
Pageof 27

Showing results (31-40 of 267) with videos related to

Sort By:
Pageof 27
Connecticut Medicine|November 1, 1970
Misplaced central venous pressure cathetersR T Schweizer, J H Foster
Therapeutic Advances in Urology|August 2, 2012
Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is bornMichael T Schweizer, Emmanuel S Antonarakis
Archives of Surgery (Chicago, Ill. : 1960)|May 1, 1988
Use of oxygen radical scavengers on autografted pig kidneys after warm ischemia and 48-hour perfusion preservationP J Bosco, R T Schweizer
Medical Hypotheses|August 1, 1986
The LAV/HTLV-III virus may evade elimination by the immune system by inducing low zone tolerance to itselfR J Sharpe, R T Schweizer
Expert Opinion on Therapeutic Targets|March 2, 2016
Targeting constitutively active androgen receptor splice variants in castration resistant prostate cancerM T Schweizer, S R Plymate
Clinical Advances in Hematology & Oncology : H&O|October 18, 2017
Prognostic and therapeutic implications of DNA repair gene mutations in advanced prostate cancerMichael T Schweizer, Emmanuel S Antonarakis
Transplantation|October 1, 1982
Effect of different magnesium levels in kidney preservation perfusateR T Schweizer, B A Sutphin
Cancer Metastasis Reviews|January 31, 2014
Immunotherapy for prostate cancer: recent developments and future challengesMichael T Schweizer, Charles G Drake
Journal of Hematology & Oncology|November 15, 2015
Persistent androgen receptor addiction in castration-resistant prostate cancerMichael T Schweizer, Evan Y Yu
Asian Journal of Andrology|January 18, 2014
Chemotherapy and its evolving role in the management of advanced prostate cancerMichael T Schweizer, Emmanuel S Antonarakis
Pageof 27